Homburger advised BioVersys AG on the deal. BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland,...
You must be a Standard 1 Year member to access this content.
VISCHER AG advised AMR Action Fund. Homburger advised BioVersys AG. The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing...
You must be a Standard 1 Year member to access this content.
MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...
You must be a Standard 1 Year member to access this content.
